Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EP 113: Your Guide to Radiation Hygiene: Insights from Manufacturer and Users
Added: 2 years ago
This week on Parallax, Dr Ankur Kalra welcomes Eric Radtke, Vice President at Worldwide Innovations & Technologies, Inc, and Barbara Breininger, a cardiovascular radiologic technologist and clinical manager with 26 years of experience.This special episode dives deep into the crucial topic of radiation hygiene, exploring it from the perspectives of both manufacturers and users of radiation safety… View more

Guidelines & Statements

Electrophysiology & Arrhythmia
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results
Author(s): Richard Pratley Added: 1 year ago
EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.Interview Questions:1. What is the reasoning behind the FLOW Trial?2. What was the patient population and study design?3. What are the key results?4. Were there any surprising or unexpected findings?5. What further… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
30th Annual Meeting of the ISCP
Author(s): Theodora Cristina Cruz de Assis , Henrique Pinheiro Rosa , Louise Buonalumi Tacito Yugar , et al Added: 1 month ago

Prevention & Chronic Conditions
EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry
Author(s): Frédéric Sacher Added: 1 year ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more

Electrophysiology & Arrhythmia
AHA 24: The BROOKLYN Study
Author(s): Stephen Nicholls Added: 1 year ago
AHA Conference 2024 - BROOKLYN: Safety and efficacy outcomes of obicetrapib (NewAmsterdam Pharma) alongside lipid-lowering therapy in Heterozygous Familial Hypercholesterolemia (HeFH) management.Dr Stephen Nicholls (Monash University and The Victorian Heart Hospital, Melbourne, AU) joins us onsite at AHA Conference to discuss the findings from BROOKLYN (NCT05425745).BROOKLYN is a phase 3,… View more

Prevention & Chronic Conditions
Author(s): Ubonwan Sapoo , Nuengruthai Phunpha , Patipan Pusopa , et al Added: 1 year ago

Anticoagulation
AHA 24 Late-Breaking Discussion: REALIZE-K
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Research Area(s) / Expertise: Job title: Chief of the Medical Physics Department